United States

Trans Genic Inc (2342.T)

2342.T on Tokyo Stock Exchange

26 Aug 2016
Change (% chg)

¥-11 (-1.86%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 2342.T


TRANS GENIC INC. is a company engaged in the biotechnology business. The Company operates in four business segments. The Genomics segment is engaged in the licensing of genetic information, the manufacturing contract of genetic knockout mice, and the gene analysis contract business, among others. The Contract Research Organizati... (more)
No analyst recommendations are available for 2342.T.


Beta: 0.67
Market Cap(Mil.): ¥8,463.08
Shares Outstanding(Mil.): 14.32
Dividend: --
Yield (%): --


  2342.T Industry Sector
P/E (TTM): 158.18 37.73 37.01
EPS (TTM): 3.74 -- --
ROI: 1.61 0.17 14.15
ROE: 1.77 -1.96 15.06

BRIEF-Trans Genic's group company to get subsidy of 3 mln yen

* Says its group company GeneticLab and a clinical research center to get subsidy of 3 million yen regarding Sapporo life sciences industry activation business

Aug 01 2016

BRIEF-Trans Genic to sell entire 30 pct stake in Kobe medicine firm for 3 mln yen

* Says it will sell entire 30 percent stake in a Kobe-based medicine company to an individual on Sep. 30

Jul 22 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : GlobalData
Provider : Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.